113 related articles for article (PubMed ID: 3001463)
1. [3H] Boc [Nle28, 31]CCK27-33, a new highly labelled ligand for CCK receptors: binding on brain and on pancreas.
Pélaprat D; Zajac JM; Gacel G; Durieux C; Morgat JL; Sasaki A; Roques BP
Life Sci; 1985 Dec; 37(26):2483-90. PubMed ID: 3001463
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of Boc [Nle28, Nle31]CCK27-33, a highly potent CCK8 analogue.
Ruiz-Gayo M; Daugé V; Menant I; Bégué D; Gacel G; Roques BP
Peptides; 1985; 6(3):415-20. PubMed ID: 2415950
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of two cholecystokinin binding sites in guinea-pig brain cortex.
Durieux C; Coppey M; Zajac JM; Roques BP
Biochem Biophys Res Commun; 1986 Jun; 137(3):1167-73. PubMed ID: 3015138
[TBL] [Abstract][Full Text] [Related]
4. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists.
Gonzalez-Muniz R; Bergeron F; Marseigne I; Durieux C; Roques BP
J Med Chem; 1990 Dec; 33(12):3199-204. PubMed ID: 1701834
[TBL] [Abstract][Full Text] [Related]
5. Characterization of [3H] CCK4 binding sites in mouse and rat brain.
Durieux C; Pélaprat D; Charpentier B; Morgat JL; Roques BP
Neuropeptides; 1988 Oct; 12(3):141-8. PubMed ID: 3241627
[TBL] [Abstract][Full Text] [Related]
6. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand.
Van Dijk A; Richards JG; Trzeciak A; Gillessen D; Möhler H
J Neurosci; 1984 Apr; 4(4):1021-33. PubMed ID: 6325601
[TBL] [Abstract][Full Text] [Related]
8. Similar potencies of CCK-8 and its analogue BOC(Nle28;Nle31)CCK27-33 on the self-stimulation behaviour both are antagonized by a newly synthesized cyclic CCK analogue.
Heidbreder C; Roques BP; De Witte P
Neuropeptides; 1989; 13(2):89-94. PubMed ID: 2739884
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of a new cholecystokinin receptor probe that can be oxidatively radioiodinated.
Pearson RK; Hadac EM; Miller LJ
Gastroenterology; 1986 Jun; 90(6):1985-91. PubMed ID: 3009263
[TBL] [Abstract][Full Text] [Related]
10. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
Knapp RJ; Vaughn LK; Fang SN; Bogert CL; Yamamura MS; Hruby VJ; Yamamura HI
J Pharmacol Exp Ther; 1990 Dec; 255(3):1278-86. PubMed ID: 2262906
[TBL] [Abstract][Full Text] [Related]
11. Characterization of central cholecystokinin receptors using a radioiodinated octapeptide probe.
Wennogle LP; Steel DJ; Petrack B
Life Sci; 1985 Apr; 36(15):1485-92. PubMed ID: 2984502
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.
Charpentier B; Dor A; Roy P; England P; Pham H; Durieux C; Roques BP
J Med Chem; 1989 Jun; 32(6):1184-90. PubMed ID: 2724293
[TBL] [Abstract][Full Text] [Related]
13. Distinct cholecystokinin receptors in brain and pancreas.
Innis RB; Snyder SH
Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6917-21. PubMed ID: 6256771
[TBL] [Abstract][Full Text] [Related]
14. Comparison of CCK-8 receptors in the pancreas and brain of rats using CCK-8 analogues.
Takeda Y; Hoshino M; Yanaihara N; Yanaihara C; Isobe J; Sugiura N; Kashimoto K; Takano Y; Kamiya H
Jpn J Pharmacol; 1989 Apr; 49(4):471-81. PubMed ID: 2724687
[TBL] [Abstract][Full Text] [Related]
15. Replacement of Tyr-SO3H by a p-carboxymethyl-phenylalanine in a CCK8-derivative preserves its high affinity for CCK-B receptor.
McCort-Tranchepain I; Ficheux D; Durieux C; Roques BP
Int J Pept Protein Res; 1992 Jan; 39(1):48-57. PubMed ID: 1378822
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
Chang RS; Chen TB; Bock MG; Freidinger RM; Chen R; Rosegay A; Lotti VJ
Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cholecystokinin receptors in bullfrog (Rana catesbeiana) brain and pancreas.
Vigna SR; Steigerwalt RW; Williams JA
Regul Pept; 1984 Oct; 9(3):199-212. PubMed ID: 6098940
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological studies with new CCK analogs: correlation with binding affinity on B-type receptors.
Böhme GA; Durieux C; Stutzmann JM; Charpentier B; Roques BP; Blanchard JC
Peptides; 1989; 10(2):407-14. PubMed ID: 2755879
[TBL] [Abstract][Full Text] [Related]
19. Characterization of receptors for cholecystokinin and related peptides in mouse cerebral cortex.
Saito A; Goldfine ID; Williams JA
J Neurochem; 1981 Aug; 37(2):483-90. PubMed ID: 6267205
[TBL] [Abstract][Full Text] [Related]
20. Investigation of peripheral cholecystokinin receptor heterogeneity by cyclic and related linear analogues of CCK26-33: synthesis and biological properties.
Charpentier B; Durieux C; Menant I; Roques BP
J Med Chem; 1987 Jun; 30(6):962-8. PubMed ID: 2438407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
